These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21930070)

  • 1. Association of heart rate variability with clinical outcome in parkinsonian patients after subthalamic deep brain stimulation: a retrospective cohort study.
    Chen SY; Yang CC; Kuo TB; Harnod T
    J Formos Med Assoc; 2011 Sep; 110(9):593-9. PubMed ID: 21930070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation].
    Furgała A; Górecka-Mazur A; Fiszer U; Pietraszko W; Thor P; Moskała M; Potasz K; Bukowczan M; Polak J; Krygowska-Wajs A
    Przegl Lek; 2015; 72(5):246-52. PubMed ID: 26817327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.
    Kleiner-Fisman G; Fisman DN; Sime E; Saint-Cyr JA; Lozano AM; Lang AE
    J Neurosurg; 2003 Sep; 99(3):489-95. PubMed ID: 12959435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial.
    Marques A; Chassin O; Morand D; Pereira B; Debilly B; Derost P; Ulla M; Lemaire JJ; Durif F
    Neurology; 2013 Aug; 81(7):633-40. PubMed ID: 23864314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
    Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
    Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Chou KL; Persad CC; Patil PG
    Parkinsonism Relat Disord; 2012 Jun; 18(5):510-3. PubMed ID: 22341622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate variability in Parkinson's disease unaffected by deep brain stimulation.
    Trachani E; Constantoyannis C; Sakellaropoulos GC; Stavrinou ML; Nikiforidis G; Chroni E
    Acta Neurol Scand; 2012 Jul; 126(1):56-61. PubMed ID: 22007954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.
    Giannicola G; Rosa M; Marceglia S; Scelzo E; Rossi L; Servello D; Menghetti C; Pacchetti C; Zangaglia R; Locatelli M; Caputo E; Cogiamanian F; Ardolino G; Barbieri S; Priori A
    Neurosignals; 2013; 21(1-2):89-98. PubMed ID: 22538235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease.
    Pahwa R; Wilkinson SB; Overman J; Lyons KE
    Stereotact Funct Neurosurg; 2005; 83(2-3):80-3. PubMed ID: 16006779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.